Epidemiological study on traditional Chinese medicine treatment for inflammatory bowel disease in Jiangsu Province from 2019 to 2023
10.3760/cma.j.cn101480-20240924-00107
- VernacularTitle:江苏省2019—2023年中医药治疗炎症性肠病的流行病学研究
- Author:
Chujun NI
1
;
Zexing LIN
;
Haiyang JIANG
;
Jie WU
;
Peizhao LIU
;
Jiaqi KANG
;
Chengliang QIAN
;
Haiqing LIU
;
Liting DENG
;
Huan YANG
;
Chenling WU
;
Yun ZHAO
Author Information
1. 南京医科大学附属明基医院外科实验室,南京医科大学外科感染与免疫临床转化研究中心,南京 210019
- Publication Type:Journal Article
- Keywords:
Inflammatory bowel disease;
Traditional Chinese medicine;
Epidemiology
- From:
Chinese Journal of Inflammatory Bowel Diseases
2025;09(4):318-325
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore patterns of traditional Chinese medicine (TCM) use among patients with inflammatory bowel disease (IBD) in Jiangsu Province, China from 2019 to 2023.Methods:Using data from the IBD health data platform of the National Healthcare Big Data (Eastern) Center, a retrospective cohort study was conducted. We performed descriptive analyses on hospitalised patients diagnosed with IBD between 2019 and 2023, who received TCM treatment.Results:The study included 11 095 case records from 4 760 patients, with TCM diagnoses primarily indicating diarrhoea and abdominal pain. Ulcerative colitis (UC) accounted for 4 782 hospitalizations (3 103 patients), while Crohn's disease (CD) accounted for 6 313 hospitalizations (1 657 patients). Patient demographics showed a trend towards younger age and a higher proportion of males. Treatment utilisation was highest in southern Jiangsu compared with the central and northern regions. In terms of disease burden, all treatment costs showed a downward trend. In terms of external TCM therapies, UC patients tend to prefer plasters and enemas, while CD patients are more inclined to use acupuncture. Regarding herbal medicine, licorice, white atractylodes, and white peony root are commonly used single herbs for IBD patients.Conclusions:The number of IBD patients treated with TCM in Jiangsu Province has steadily increased from 2019 to 2023. It is important to identify effective TCM treatment methods to reduce the burden of patients.